Abstract:PURPOSE:To evaluate the feasibility of using magnetic resonance (MR) imaging and single photon emission computed tomography (SPECT)/computed tomography (CT) to visualize the in vivo recruitment of iron oxide-labeled macrophages and indium 111 ((111)In)-labeled macrophages in inflammatory bowel disease (IBD) and to monitor disease activity.MATERIALS AND METHODS:This study had institutional animal care and use committee approval. Twenty-seven C57/B6 mice with dextran sodium sulfate (DSS)-induced IBD and control mice were included. Peritoneal macrophages were harvested from seven thioglycollate-treated mice and were labeled with superparamagnetic iron oxide (SPIO) nanoparticles. Macrophage iron content was determined by using inductively coupled plasma mass spectrometry. SPIO nanoparticle-labeled macrophages (5 × 10(6)) were intravenously administered. Mice with DSS-induced IBD (n = 8) and control mice (n = 6) were imaged with a 9.4-T MR imaging unit at 0, 5, and 24 hours after macrophage administration. Percentage normalized enhancement (NE) was calculated for the intestinal wall and liver 24 hours after injection. Six mice with IBD coinjected with SPIO nanoparticles and (111)In oxine-labeled macrophages were imaged with MR imaging and SPECT/CT after 24 hours. The pharmacokinetics and biodistribution of the implanted macrophages were determined. Correlation between percentage NE and IBD scores was calculated.RESULTS:Ex vivo mass spectrometry revealed strong SPIO nanoparticle uptake (7.4 pg iron per cell). R2* correlated with cell number (r = 0.9813, P < .05). Percentage NE correlated with both clinical (r = 0.924) and pathologic (r = 0.795) IBD score. Cell circulation half-life in the first and second phases was 0.32 hour and 10.2 hours, respectively. SPECT/CT showed that approximately 3% of the injected dose was present in the intestines 24 hours after injection; this was confirmed at MR imaging and histologic examination. Indium 111-labeled cells were present in all tissue associated with the reticuloendothelial system or mononuclear phagocyte system at 24 hours.CONCLUSION:SPIO nanoparticles and (111)In-labeled macrophages could be observed in vivo at MR imaging and SPECT/CT in mice with IBD. Percentage NE at MR imaging correlates with disease activity.

A prospective study of macrophage migration inhibitory factor as a marker of inflammatory detection.

Radioiodine Labeled Anti-Mif Mcab: A Potential Agent for Inflammation Imaging

Biodistribution of ~(125)I Labeled Recombinant Macrophage Migration Inhibitory Factors in Inflammatory Model of Mice

Evaluation of macrophage migration inhibitory factor as an imaging marker for hepatocellular carcinoma in murine models.

Preparation of anti-mMIF monoclonal antibodies and their radio-iodinated labeling

[Preparation and Biologic Activity Study of (125);I-Labeled Anti-Mif Monoclonal Antibody].

Evaluation of 131I-anti-MIF mAb as a reporter for allograft rejection.

Biodistribution of 125I Labeled Anti-Mif McAb in the Skin Allograft Rejection of Mice

Bio-distribution and tumor targeting of 131 I-rMIF in tumor-bearing mice

Effect of α-melanocyte-stimulating hormone on the expression ofmacrophage migration inhibitory factor in various tissues of rats withexpeimentally induced endotoxemia

Plasma Macrophage Migration Inhibitor Factor is Elevated in Response to Myocardial Ischemia

Development of A Novel Method to Measure Macrophage Migration Inhibitory Factor (mif) in Sera of Patients with Rheumatoid Arthritis by Combined Electrochemical Immunosensor

Comparison of Biodistribution of Monoclonal Antigranulocyte Antibody and HIG in Inflammatory Model Mice

Inflammatory Bowel Disease: MR- and SPECT/CT-based Macrophage Imaging for Monitoring and Evaluating Disease Activity in Experimental Mouse Model—Pilot Study

Expression of Macrophage Migration Inhibitory Factor in Acute Ischemic Myocardial Injury

Molecular Imaging of Folate Receptor Β-Positive Macrophages During Acute Lung Inflammation.

Inflammatory stimuli impact on cellular uptake and biodistribution of perfluorocarbon nanoemulsions

18 F-PBR06 PET/CT Imaging of Inflammation and Differentiation of Lung Cancer in Mice

Molecular Imaging with Macrophage Crig-Targeting Nanobodies for Early and Preclinical Diagnosis in A Mouse Model of Rheumatoid Arthritis

Prognostic Significance and Dynamic Change of Plasma Macrophage Migration Inhibitory Factor in Patients with Acute ST-elevation Myocardial Infarction.

In Vivo Imaging of the Macrophage Migration Inhibitory Factor in Liver Cancer with an Activity-Based Probe